Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:ceo |
gptkb:Dr._T._J._Mc_Carthy
|
| gptkbp:clinical_trial |
pneumococcal vaccines
|
| gptkbp:collaborations |
gptkb:University_of_Massachusetts_Medical_School
|
| gptkbp:focus |
vaccine development
|
| gptkbp:founded |
gptkb:2013
|
| gptkbp:goal |
improve vaccine efficacy
|
| gptkbp:headquarters |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Affinivax
|
| gptkbp:investment |
gptkb:Flagship_Pioneering
|
| gptkbp:notable_products |
Multivalent vaccines
|
| gptkbp:partnership |
gptkb:Bill_&_Melinda_Gates_Foundation
|
| gptkbp:research_areas |
infectious diseases
|
| gptkbp:technology |
Avi Vax platform
|
| gptkbp:type_of |
conjugate vaccines
|
| gptkbp:website |
www.affinivax.com
|